| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3865108 | The Journal of Urology | 2010 | 7 Pages |
Abstract
Epigenetic analysis revealed that myopodin methylation was associated with tumor aggressiveness and clinical outcome in patients with T1G3 disease. Myopodin methylation distinguished patients responding to bacillus Calmette-Guerin from those who may require a more aggressive therapeutic approach.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Miguel Alvarez-Múgica, Virginia Cebrian, Jesus M. Fernández-Gómez, Florentino Fresno, Safwan Escaf, Marta Sánchez-Carbayo,